Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nina-Sophie Schmidt-Hegemann"'
Autor:
Chukwuka Eze, Nina Sophie Schmidt-Hegemann, Farkhad Manapov, Minglun Li, Maurice Dantes, Julian Guggenberger, Olarn Roengvoraphoj, Arteda Gjika, Claus Belka, Julian Taugner, Lukas Käsmann
Publikováno v:
Acta Oncologica. 60:1074-1078
Concurrent platinum-based chemoradiation (CRT) followed by consolidation PD-L1 inhibition with durvalumab is the standard of care for patients with inoperable stage III NSCLC [1]. However, in high-...
Autor:
Arndt-Christian Müller, Constantinos Zamboglou, Pirus Ghadjar, Thomas Wiegel, Stefan Höcht, Daniel Zips, Michael Pinkawa, Frank Wolf, Ute Ganswindt, Tobias Hölscher, Clemens Albrecht, Nina-Sophie Schmidt-Hegemann, Daniel M. Aebersold, Peter Niehoff, Dirk Böhmer, Felix Sedlmayer, Michael Flentje
Publikováno v:
Wolf, Frank; Sedlmayer, Felix; Aebersold, Daniel; Albrecht, Clemens; Böhmer, Dirk; Flentje, Michael; Ganswindt, Ute; Ghadjar, Pirus; Höcht, Stefan; Hölscher, Tobias; Müller, Arndt-Christian; Niehoff, Peter; Pinkawa, Michael; Schmidt-Hegemann, Nina-Sophie; Zamboglou, Constantinos; Zips, Daniel; Wiegel, Thomas (2021). Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer. Strahlentherapie und Onkologie, 197(2), pp. 89-96. Springer 10.1007/s00066-020-01723-8
Due to its low fractionation sensitivity, also known as “alpha/beta ratio,” in relation to its surrounding organs at risk, prostate cancer is predestined for hypofractionated radiation schedules assuming an increased therapeutic ratio compared to
Autor:
Nina-Sophie Schmidt-Hegemann, Boris Schlenker, Minglun Li, Alexander Kretschmer, Christian G. Stief, Alexander Buchner, Claus Belka, Thilo Westhofen, Armin J. Becker
Publikováno v:
The Journal of urology. 206(5)
The optimal timing of radiotherapy (RT) after radical prostatectomy (RP) remains controversial with unknown impact on health-related quality of life (HRQOL). We aimed to compare the influence of early RT (eRT) and deferred RT (dRT) on HRQOL.A total o
Autor:
Alexander Buchner, Run Shi, Nina-Sophie Schmidt-Hegemann, Rieke von Bestenbostel, Christian Trapp, Minglun Li, Claus Belka, Christian G. Stief, Mack Roach, Paul Rogowski
Publikováno v:
Radiation oncology (London, England), vol 16, iss 1
Radiation Oncology, Vol 16, Iss 1, Pp 1-16 (2021)
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-16 (2021)
Radiation Oncology (London, England)
Background Due to improved imaging sensitivity, the term “oligometastatic” prostate cancer disease is diagnosed more often, leading to an increasing interest in metastasis-directed therapy (MDT). There are two types of radiation based MDT applied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97b6868935fe38c380a9e061550aaf4
https://escholarship.org/uc/item/0vt321qg
https://escholarship.org/uc/item/0vt321qg
Autor:
R. Abdo, Maurice Dantes, Chukwuka Eze, Farkhad Manapov, Olarn Roengvoraphoj, Lukas Käsmann, Claus Belka, Nina-Sophie Schmidt-Hegemann
Publikováno v:
Anticancer Research. 38:5261-5265
Background/Aim: The general pattern of care regarding the application of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) patients in Germany has not been previously evaluated. This survey was conducted to assess patterns of ca
Autor:
Christian G. Stief, A. Kretschmer, V. Wenter, Claus Belka, C. Trapp, J. Milow, Harun Ilhan, Paul Rogowski, Chukwuka Eze, Minglun Li, Alexander Buchner, Nina-Sophie Schmidt-Hegemann
Publikováno v:
Radiotherapy and Oncology. 161:S643-S644
PD-0909 Outcomes of metastasis-directed treatment of bone oligometastatic disease in prostate cancer
Autor:
Claus Belka, Run Shi, Paul Rogowski, J. Ma, Nina-Sophie Schmidt-Hegemann, Minglun Li, Christian Trapp, R. von Bestenbostel
Publikováno v:
Radiotherapy and Oncology. 161:S751-S752
Autor:
Lukas Käsmann, Chukwuka Eze, Julian Taugner, Maurice Dantes, Farkhad Manapov, Nina-Sophie Schmidt-Hegemann, Olarn Roengvoraphoj, Sanziana Schiopu, Claus Belka
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-14 (2020)
Radiation Oncology, Vol 15, Iss 1, Pp 1-14 (2020)
Immune-checkpoint inhibitors (ICI) have dramatically changed the landscape of lung cancer treatment. Preclinical studies investigating combination of ICI with radiation show a synergistic improvement of tumor control probability and have resulted in
Autor:
Lino M Sawicki, Franziska Walter, Nina-Sophie Schmidt-Hegemann, Chukwuka Eze, Farkhad Manapov
Publikováno v:
JAMA Oncol
J Thorac Dis
J Thorac Dis
IMPORTANCE: Effective treatment options for locally advanced esophageal cancer are limited, and rates of local recurrence after standard chemoradiotherapy remain high. OBJECTIVE: To evaluate toxic effects, local control, and overall survival rates af
Autor:
Nina-Sophie Schmidt-Hegemann, Minglun Li, Christian G. Stief, Alexander Buchner, Shun Lu, Claus Belka, Run Shi, Xuanwen Bao, Paul Rogowski, Christian Schäfer, Kristian Unger, Jing Sun
Publikováno v:
Cancers, Vol 12, Iss 1146, p 1146 (2020)
Cancers
Cancers 12:1146 (2020)
Volume 12
Issue 5
Cancers
Cancers 12:1146 (2020)
Volume 12
Issue 5
More accurate models are essential to identify high-risk bladder cancer (BCa) patients who will benefit from adjuvant therapies and thus helpful to facilitate personalized management of BCa. Among various cancer-related hallmarks and pathways, cell c